Search

Renown Health is pleased to announce that Kate A. Ward, Pharm.D., BCPS, has been promoted to serve as Vice President, Oncology for Renown Regional Medical Center.    Dr. Ward has over fourteen years of service to the organization, most recently as Director of Clinical Pharmacy responsible for the oversight of all clinical pharmacy activities at Renown Regional Medical Center, Renown South Meadows Medical Center, and Renown Rehabilitation Hospital. Additionally, Dr. Ward is the Residency Director of the Post-Graduate Year 1 (PGY1) Pharmacy Practice Residency at Renown. Over the last decade at Renown, Dr. Ward has served as Pharmacy Clinical Manager, Pharmacy Clinical Coordinator and Clinical Pharmacist.   Dr. Ward will bring her pharmacy clinical service experience (including ICU, Outpatient Infusion, Pediatrics, Oncology and Emergency Services), Inpatient Care, Clinical Research, and Hospital Formulary Management, Electronic Medical Record Integration and Optimization to this important new role.   As a dyad partner with Max J. Coppes, MD, PhD, MBA, Director of the William N. Pennington Cancer Institute at Renown, she will bring her clinical, operational, regulatory, and administrative experience to lead the oncology division. Dr. Ward, Dr. Coppes and the dedicated team will advance Renown’s mission to expand care, prevention, screening, research, and education with the goal of establishing the first National Institutes of Health, NCI designated Cancer Center for our State.   “We are thrilled to welcome Dr. Ward as our new Vice President of Oncology. She brings a wealth of experience and a passion for advancing patient care. Dr. Ward will play a pivotal role in sharing the future our oncology division and furthering our commitment to providing exceptional care,” said Chris Nicholas, CEO of Renown Regional Medical Center.    As a licensed pharmacist, Dr. Ward holds a Doctor of Pharmacy degree from the University of Colorado, Health Sciences Center. The Pharm.D. is a professional degree like a Doctor of Medicine (MD) or Doctor of Dental Surgery (DDS). As a doctorate, it represents the increasing responsibility pharmacists have in healthcare systems and the high trust Americans have in pharmacists.    Dr. Ward completed her residency at Stanford Hospital and Clinics. She graduated from the University of Nevada, Reno with her bachelor’s degree in Nutritional Sciences. Dr. Ward is active in several professional associations and currently serves as a Pharmacy Board member for HealthTrust; Vice Chair of the American Society of Health System Pharmacists® Council on Therapeutics; and Vice Chair for the Silver State Scripts Board for the State of Nevada. Dr. Ward was the 2022 recipient of the Nevada Society of Health System Pharmacists (NVSHP) President’s Award. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit renown.org/careers.

Read More About Exceptional Talent Joins William N. Pennington Cancer Institute at Renown; Dr. Kate Ward Brings Expertise and Vision as Vice President of Oncology Division

Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

Read More About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

Renown Health is pleased to announce the appointment of Anna Loomis, MBA, as its new Chief Financial Officer (CFO), effective July 1, 2024. Ms. Loomis will oversee all aspects of financial management for Renown Health including budgeting, financial planning, revenue cycle management, supply chain and strategic investments for Nevada’s #1 ranked health care organization.    Before joining Renown, Ms. Loomis served as Senior Vice President (SVP) and CFO with Portland-based Legacy Health, and prior to that as SVP and Chief Financial Officer for Washington-based MultiCare for more than 15 years.  With over 20 years in finance leadership and strategy, Ms. Loomis has led several transformative efforts to strengthen the organizations and build partnerships.    “We are thrilled to welcome Anna Loomis to our executive team,” said Brian Erling, MD, MBA, President & CEO for Renown Health. “Anna is an approachable, innovative, and resilient leader. Her proven track record of financial stewardship and her deep understanding of the complexities of the healthcare landscape make her an ideal fit for the team. The essential role that Renown Health plays as the only local, not-for-profit, charitable healthcare network in Washoe County will be furthered by her commitment. We are confident that with her guidance and expertise, we will continue to strengthen our financial position while advancing our mission to deliver the highest quality care and service to patients.”    Anna earned her master’s and bachelor’s degree in business administration from Pacific Lutheran University (Tacoma, WA); completed a finance fellowship with The Academy GE Fellows Program and serves on the Board of Directors for PacificSource health plans.   As of Aug. 2023, Fitch Ratings affirmed the 'A+' long-term rating on the series 2020A, 2020B, 2015A and 2016A bonds issued on behalf of Renown Health, NV by Public Finance Authority (Renown Regional Medical Center Project). In addition, Fitch has affirmed Renown's IDR at 'A+'. Renown's 'A+' revenue bond ratings and the Outlook revision to Stable are primarily driven by the system's midrange operating risk profile assessment, which has rebounded significantly over the past 12-months. Both the rating and Stable Outlook incorporate Renown's position as the service area's single largest provider of high-end acute care services and maintenance of the leading market position, with approximately two-thirds of all patients in northern Nevada seeking care at Renown. The rating is further informed by Renown's solid balance sheet metrics, which remain intact at or near historical levels. Given significant consumer demand for Renown providers and services, a master facility planning process and strategic planning process has been undertaken to ensure that Renown has adequate bed and procedure capacity, spaces to accommodate new technology and services to meet the needs of a growing patient base and community. As the region’s only Level 2 Trauma Center for both adults and children, Renown serves over 1 million people and 100,000 square miles across Nevada, Lake Tahoe, and northeast California. In U.S. News and World Report Best Hospital Rankings, Renown Regional Medical Center has been named #1 in the State of Nevada for the last three years.   Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,200 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. For more information, visit renown.org.

Read More About Renown Health Appoints Anna Loomis MBA As Chief Financial Officer

Amy McGaha, MD, MPH, FAAFP has joined the University of Nevada, Reno School of Medicine (UNR Med) and Renown Health as department chair of Family and Community Medicine. Dr. McGaha comes to Nevada from Omaha, Nebraska where she served as the Roland L. Kleeberger, MD professor and chair for the Creighton University School of Medicine, Department of Family Medicine.  Dr. McGaha previously served as the assistant director of medical education for the American Academy of Family Physicians (AAFP), the professional membership association for family physicians, working to develop family medicine workforce and medical education. She has also served on the Board of Trustees for the Society of Teachers of Family Medicine and on the board for CHI Health, the clinical partner of Creighton University School of Medicine. Prior to those appointments, Dr. McGaha provided inpatient and outpatient care for Freeman Health Systems in Missouri. Dr. McGaha completed her education at the University of Missouri School of Medicine in Columbia and completed her residency in family medicine in Tallahassee, Florida. Dr. McGaha also completed a Master of Public Health (MPH) degree at the Milken Institute School of Public Health at George Washington University. She is a fellow of the AAFP. Dr. McGaha will serve as the joint academic and administrative leader defining clinical operations to expand care, enhancing teaching and training programs vital to ambulatory and acute care medicine in northern Nevada and fostering clinical and translational research and diversity missions. “I am delighted to welcome Dr. McGaha,” said Paul J. Hauptman, MD, dean of UNR Med and chief academic officer for Renown Health. “As our new chair for Family and Community Medicine, she brings to us a wealth of experience, dedication and innovation that will continue to elevate the quality of care we provide to patients and the excellence in education we offer to students. Dr. McGaha has a strong background in academic medicine, distinction in clinical care, medical education, and research, and is universally respected as a compassionate physician leader. Dr. McGaha will do much to advance the mission of our Family Medicine Residency program and expand related Graduate Medical Education (GME) opportunities, shaping the future of family medicine in northern Nevada and beyond.” “Dr. McGaha will help bolster our commitment to providing exceptional primary care services to our community. With her guidance, we will advance patient-centered care, train the next generation of health care professionals and foster a culture of innovation within our academic health system,” said Brian Erling, MD, MBA, president and CEO of Renown Health. “This is an exciting time for Dr. McGaha to help craft our vision to offer more efficient and affordable care, elevate the patient experience and advance health equity across northern Nevada. We are fortunate to have her joining our team and our community.” Dr. McGaha will spearhead initiatives to enhance clinical outcomes, promote preventative health measures and foster collaboration among health care providers to optimize patient care delivery. In addition, Dr. McGaha will oversee the Family Medicine Residency, a full-scope, fully accredited program at UNR Med. Graduates practice in various settings, both rural and urban, solo family medicine and in large provider groups, traditional outpatient family medicine and as hospitalists or urgent care physicians. Dr. McGaha’s research has explored maternal health equity. She designed a Medical-Financial Collaborative Care Practice Model to address social determinants of health in patients with Type 2 diabetes. She has also presented nationally on diverse topics, such as “Advancing Inclusion and Belonging in Health Science Education” and “Innovating Interprofessional Collaboration in a Primary Care Setting.” An author of 25 academic papers, she has a long history of community service to schools, hospice organizations and neighborhood health clinics. Dr. McGaha has won many awards for her work in medical education, including the AIHC Interprofessional Practice Award, induction into the Gold Humanism Honor Society at Creighton University, the AAFP Foundation Pfizer Immunization Grant Award, the Physicians Recognition Award from the American Medical Association, and the Ellen Beck Faculty Award for Medical Staff Outstanding Commitment. The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents, and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national, and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu. Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health.

Read More About Amy McGaha, MD, MPH, FAAFP Appointed Chair of Family and Community Medicine

Gilead Sciences, Inc. (Nasdaq: GILD) and the Renown Institute for Health Innovation (IHI) today announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance the understanding of nonalcoholic steatohepatitis (NASH) and potentially inform development of treatment options for the disease. Under the terms of the collaboration and license agreement, Gilead will provide funding to Renown IHI to sequence and analyze the DNA of 15,000 individuals living with NASH or nonalcoholic fatty liver disease (NAFLD) as well as a control cohort of 40,000 individuals in Nevada. “Combining the sequencing of protein coding DNA, with extensive electronic health record data will enable a deep analysis of the roles of genetics and environment in NASH incidence and progression,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “The analysis of these large datasets in collaboration with Renown IHI could help identify genetic variants that impact the risk of developing NASH and thereby advance the discovery and development of new treatments for this disease.” Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has 40,000 participants. “Combining genetic sequencing with large sets of data can play a critical role in understanding and identifying serious health risks, including diseases like NASH. We are excited to collaborate with Gilead to better understand the condition and its complexities,” said Anthony Slonim, MD., DrPH. “Any genetic variants identified in participants through the collaboration may be shared with the participants for patient care purposes.”     About NASH Nonalcoholic steatohepatitis (NASH) is a chronic form of liver disease characterized by excess fat in the liver, inflammation, and liver cell damage. Inflammation and liver cell damage can cause scarring of the liver, or fibrosis, and ultimately lead to cirrhosis or liver cancer. NASH is more common in people with certain conditions, including obesity and type 2 diabetes. There are currently limited approved treatments for patients living with NASH.   About Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.   About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. Renown Health works to improve health care through science, research and genetics; forge community partnerships that improve lives and develop innovative models that are improving health care in Nevada. For more information, visit renown.org.    About Helix Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by their proprietary Exome+™ assay—a panel-grade exome enhanced by more than 300,000 informative non-coding regions—Helix offers health systems a scalable solution which enables the discovery of medically relevant, potentially life-saving, genetic information. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery. Helix is headquartered in the San Francisco Bay Area and has one of the world’s largest CLIA-certified, CAP-accredited Next Generation Sequencing labs, located in San Diego, California. Learn more at www.helix.com. Helix, the Helix logo, and Exome+ are trademarks of Helix Opco, LLC.   Gilead Forward-Looking Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration, and Gilead may fail to discover, develop and commercialize any product candidates for the treatment of NASH. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.   Additional Media Contact: Sung Lee, Investors                                                                                                                                                        650-524-7792 Arran Attridge, Media                                                                                                                                                        650-425-8975

Read More About Gilead Sciences and Renown Institute for Health Innovation Announce Strategic Collaboration to Advance Understanding of Nonalcoholic Steatohepatitis (NASH)

New contract protects affordability for Northern Nevada Consumers. Anthem Blue Cross Blue Shield (Anthem) and Renown Health (Renown) today announced they have reached an agreement on a new contract. The agreement protects affordability and provides Anthem members with continued in-network access to all Renown hospitals and physicians. This agreement applies to Anthem consumers enrolled in employer based HMO and PPO plans and provides continued in-network access to Renown affiliated care providers and facilities. “We are pleased to continue working with Renown to maintain and improve access to healthcare for consumers and employers in Northern Nevada. Our members remained our number one priority as we worked hard and in good faith to find common ground and reach an agreement that helps achieve greater affordability,” said Mike Murphy, president, Anthem Blue Cross Blue Shield of Nevada. “We value the relationships we have with the care providers in our network, which are important to creating choices for our consumers and fulfilling our mission of improving the lives of the people in the communities we serve.” Anthony Slonim, MD, D.Ph., FACHE, President and CEO of Renown Health stated, “We appreciate the collaborative approach of both teams to reach resolution. As this community’s only not-for-profit healthcare organization, our mission is to make a genuine difference in the health and well-being of the community. As doctors, nurses and care givers, we want to ensure the greatest access, experience and highest-quality care for every member of our community including those insured by Anthem.” Consumers with questions can contact Anthem by using the toll-free number on the back of their current Anthem identification card or going to anthem.com/renown.     About Anthem Blue Cross Blue Shield: Anthem Blue Cross Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products are underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensees of the Blue Cross and Blue Shield Association. ®ANTHEM is a registered trademark of Anthem Insurance Companies, Inc. The Blue Cross and Blue Shield names and symbols are registered marks of the Blue Cross Blue Shield Association. Additional information about Anthem Blue Cross Blue Shield in Nevada is available at www.anthem.com. Also, follow us on Twitter @AnthemBCBS or @AnthemBCBS_News and on Facebook at Anthem Blue Cross Blue Shield.   About Renown Health: Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest employers with a workforce of more than 7,000. It comprises three acute care hospitals, a children’s hospital, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. For more information, visit www.renown.org.Additional Media Contacts:Mike BowmanAnthem Blue Cross Blue Shieldmichael.bowman@anthem.com916-584-6043

Read More About Anthem Blue Cross Blue Shield and Renown Health Announce New Contract Agreement

Renown Health Board of Directors Chair, Jim DeVolld, Receives Nevada Hospital Association’s Commitment to Community Award for Trustee Excellence Award. Renown Health Board of Directors Chair, Jim DeVolld has been awarded the prestigious 2019 Commitment to Community Award for Trustee Excellence from the Nevada Hospital Association (NHA). Each year at the association’s annual meeting, the Nevada Hospital Association publicly acknowledges one trustee who exemplifies exceptional leadership and the characteristics to which all hospital and health system Board leaders should aspire, including: Professional excellence Outstanding achievements Innovative accomplishments Extraordinary compassion in caring for the community Success in overcoming barriers, and Exemplary contributions to effectively advocate on behalf of hospitals, patients, and the healthcare system. “Jim DeVolld’s personal connection and passion for improving the community’s overall health are what drive his commitment to the Renown Health Board,” NHA’s President & CEO, Bill Welch said. “Under Jim’s leadership, Renown Health is nationally recognized for top levels of quality and safety, most notably through advances made in clinical care, the adoption of health information technology and the development of team-based and patient-centered medical homes.” DeVolld was nominated by President & CEO of Renown Health, Anthony D. Slonim, MD, D.Ph. and his senior leadership team at Renown Health. Through Jim and the Boards’ support, the integrated healthcare system now includes four hospital campuses, 120 sites of primary, urgent and specialty care, affiliations with Stanford Medicine, the University of Nevada-Reno Medical School, St. George’s University in Grenada (SGU) School of Medicine, and a health plan, Hometown Health that serves more than 180,000 members. Renown Health’s more than 7,000 employees and 800 providers serve as the regional referral care center for over 100,000 square miles, from Sacramento to Salt Lake City. An essay was submitted describing DeVolld’s leadership of the 43 member Renown Health Board of Directors with deep admiration and chronicled a long list of organizational accomplishments. One nominee stated, “Jim sets a stellar example as a Board Chair who tirelessly advocates for improvement, inclusion, responsibility, preparation, taking the ‘high road,’ and the importance of collaborative, positive relationships. Jim’s commitment has extended beyond traditional healthcare to include economic health and community health and well-being. "A lifelong Nevadan, Jim DeVolld grew up in Yerington before moving to Reno 31 years ago. Jim DeVolld’s32-year-old daughter was born at Renown Regional Medical Center and his family receives care at Renown Health. Jim DeVolld’s personal connection and passion for improving the community’s overall health are what drive his commitment to the Renown Health Board. To ensure the world-class care our community expects and deserves, he has focused first on caring for Renown’s 7,000 employees who provide outstanding care every day. After eight years serving in various roles with Renown Health’s board of directors, Jim DeVolld, managing director, commercial banking at First Independent Bank, was elected as the chairman of the board, Renown Health for a two-year term, effective January 1, 2019. Renown’s four governing boards serve a key role in achieving Renown’s mission of making a genuine difference in the health and well-being of the people and communities in Northern Nevada. Board members help guide the health system with the charitable mission of “making a genuine difference in the health and well-being,” based on the principles of caring, integrity, collaboration and excellence. Jim DeVolld has spent decades working in the Northern Nevada banking industry. He also serves as chairman of the Nevada Tax Commission and is a board member of the Boys and Girls Club of Truckee Meadows.     About the NHA The Nevada Hospital Association is a not-for-profit, statewide trade association representing Nevada’s acute care hospitals along with psychiatric, rehabilitation and other specialty hospitals as well as health related agencies and organizations throughout the state. Allied with the American Hospital Association, the NHA is an independent organization headquartered in Reno, Nev. About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. For more information, visit renown.org.

Read More About Renown Board of Directors Chair, Jim DeVolld, Receives NHA Award

Renown Health CEO, Dr. Tony Slonim Elected to Highest Office with American Hospital Association.  Renown Health President and CEO, Anthony Slonim, M.D., DrPH, FACHE, has been elected to serve as a member of the American Hospital Association (AHA) Board of Trustees for a three-year term beginning Jan. 1, 2022. The Board of Trustees is the highest policymaking body of the AHA and has ultimate authority for the governance and management of the organization. The American Hospital Association (AHA) is the national organization that represents over 40,000 individual members and serves over 5,000  hospitals, health care networks, and their patients and communities. As a representative and advocate for those serving in the health care field, Dr. Slonim's role as a Trustee will be to ensure that members' perspectives and needs are heard and addressed in national health policy development, legislative and regulatory debates, and judicial matters. Dr. Slonim joins an elite list of CEOs from the nation’s most respected health care organizations in AHA Board service, including Yale New Haven Health (CT), Dartmouth Hitchcock Health (NH), Providence Health (WA), Henry Ford Health (MI), UMass Memorial Health (MA), Vanderbilt University Medical Center (TN), and Advocate Aurora Health (WI). The American Hospital Association was founded in 1898, the same year Marie Curie began studying uranium as a treatment for cancer. Dr. Slonim is among the first health care leaders from Nevada elected to serve on the AHA Board of Trustees. In an announcement to the national media, the AHA wrote, “Anthony Slonim, MD, DrPH, leads Renown's charitable mission of making a genuine difference in the community's health and well-being for one of the nation's most innovative and progressive health systems.” Steve Sisolak, Governor of the State of Nevada, in support of Dr. Slonim’s nomination wrote, “Both Dr. Slonim and I share a common interest for improving the health of over 3 million residents of our state. I urge you to appoint him to this position, as his national leadership would benefit the American Hospital Association, our state and our nation.” Brian Sandoval, President of the University of Nevada wrote in his nomination, “Dr. Slonim has always answered the call, and worked with me to improve health through proactive community-based prevention, to create an exceptional healthcare system for those with acute and chronic diseases, and to care for all people in our community.” Bill Welch, President and CEO of the Nevada Hospital Association, wrote in support, “I consider Dr. Anthony Slonim  to be one of the most extraordinary leaders in health care today.” Dr. Slonim is recognized nationally as a thought and opinion leader who does not accept the status quo. He is a quadruple board-certified physician by training and holds a Doctorate in Public Health and Health Policy with Fellowships in the American College of Healthcare Executives (ACHE), American Association of Physician Leaders (AAPL), and the College of Critical Care Medicine. Dr. Slonim’s holds a university appointment at the University of Nevada, Reno School of Medicine, is a highly sought after speaker on healthcare trends and leadership development, holds a Six Sigma Black Belt and is a 2-time TEDx speaker. Dr. Slonim has authored more than 120 publications, 15 textbooks, and has millions of dollars in research funding to his name. Modern Healthcare has named Dr. Slonim as one of the 50 Most Influential Leaders in Healthcare. He has been named to Becker's Hospital Review's "Physician Leaders to Know" list since 2014. Before joining Renown Health in 2014, Slonim served on the senior leadership teams for Barnabas Health in New Jersey, Carilion Clinic in Virginia and Children's National Medical Center in Washington, D.C. Slonim, who was also a registered nurse, got his medical degree from New York Medical College, served four years in the U.S. Public Service Commissioned Corps as a commander, and earned both his master's and doctoral degrees in public health and health policy from The George Washington University's Center for Health Policy Studies.     About Renown Health Renown Health is a locally governed, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown has a long tradition and commitment to improving the care and the health of our community. For more information, visit renown.org.

Read More About Prestigious Honor Shines National Spotlight on Health Care in Nevada

Softheon and Hometown Health, Nevada's largest not-for-profit insurance company, have formed a partnership to serve Nevadans enrolling through Nevada Health Link state-based ACA marketplace. Nevada's largest not-for-profit health insurance company, Hometown Health, has entered the Affordable Care Act (ACA) marketplace and has expanded their health plan offerings through a partnership with Softheon, a leading cloud-based health insurance exchange and service provider. Softheon's innovative platform is helping bring quality health care to Nevada residents enrolling in Hometown Health insurance through Nevada Health Link. “Softheon’s expert knowledge of the ACA marketplace coupled with their leading enrollment and billing technology has made them the perfect partner during Hometown Health’s first open enrollment period on the exchange,” said David Hansen, Hometown Health CEO. “Today, more than 100,000 people in Nevada choose Hometown Health for their insurance needs. Thanks to Softheon, we look forward to expanding insurance coverage options, in a way that is simple and convenient, to our friends and families who use Nevada Health Link.” Since the beginning of the 2021 open enrollment period, over 800 new members have seamlessly enrolled in Hometown Health’s insurance thanks to Softheon’s cutting-edge software. The partnership with Softheon will improve member enrollment, billing and communications, enabling Hometown Health to remain focused on their core mission of providing excellent healthcare to Nevada residents. As the health insurance division of Renown Health, northern Nevada’s leading healthcare provider, Hometown Health offers members competitive rates and the largest network of providers in the region. Renown Health provides advanced medical services including Renown Regional Medical Center, an 808-bed full service regional hospital, Renown South Meadows Medical Center, a 76-bed acute care community hospital, Renown Children’s Hospital, the region’s only children’s hospital with 83 beds, and Renown Rehabilitation Hospital, a 62-bed rehabilitation hospital. These facilities provide quality healthcare for Renown's primary service area, Washoe County and the secondary service areas of northern Nevada and northern California. Renown Health has more than 7,000 employees and serves northern Nevada, Lake Tahoe and northeast California with a total population in excess of 2 million. In addition to hospitals, Renown also has 110 medical group practice sites, urgent care and outpatient imaging sites. Renown Health and Hometown Health offer advanced care for patients and embrace their role in improving the health and well-being of the people and communities. “The continued growth of the Affordable Care Act marketplace is welcome news for consumers who are seeking more options for accessing health coverage,” said Eugene Sayan, CEO and founder of Softheon. "We are excited to partner with Hometown Health on their entrance into the ACA marketplace to create seamless experiences for their members and connect more individuals in Nevada with quality health care.” Along with improving member enrollment, billing and communications, Softheon helps Hometown Health continue to ensure accuracy through monthly Advanced Premium Tax Credits premium reconciliation. The turnkey solution provided by Softheon has guided Hometown Health in handling all regulatory and operational requirements required of insurers in the ACA marketplace. The partnership has given Hometown Health the opportunity for expanded reach while making a bigger impact on communities across the state. To learn more about Softheon, visit www.softheon.com. To learn more about Hometown Health, visit www.hometownhealth.com.     About Softheon Founded in 2000, Softheon’s Software-as-a-Service (SaaS) and Business Process-as-a-Service (BPaaS) solutions solve complex challenges for health plans and government health agencies. Currently, Softheon’s solutions serve 8 State agencies and over 90 health plans. Issuers and consumers utilizing Medicaid, Medicare, and the ACA Marketplace benefit from Softheon’s innovative technology that reduces administrative overhead and enhances user-experiences. Softheon is an Agent, Broker, and Merchant of Record that facilitates health insurance enrollment, billing, and renewal.   About Hometown Health Established in 1988, Hometown Health is the insurance division of Renown Health and is northern Nevada's largest local, not-for-profit health insurance company. Providing wide-ranging medical coverage and great service to members, Hometown Health represents a philosophy of health care that emphasizes active partnerships between members and physicians. For more information, call 775-982-3000 or visit www.hometownhealth.com.

Read More About Hometown Health Enters Affordable Care Act Marketplace